Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancer
AssigneeGenmab A/S
InventorsReshma A. RANGWALA, Steen LISBY
Life of this patent
Estimating the term…
Abstract
The invention provides methods and compositions for treating cancer, such as advanced cervical cancer, in a subject, such as by the administration of antibody-drug conjugates that bind to tissue factor (TF). The invention also provides articles of manufacture and compositions comprising said antibody drug-conjugates that bind to TF for use in treating cancer (e.g., advanced cervical cancer).
Claims29
A method of treating cervical cancer in a subject, the method comprising administering to the subject an antibody-drug conjugate that binds to tissue factor (TF), wherein the antibody-drug conjugate comprises an anti-TF antibody or an antigen-binding fragment thereof conjugated to a monomethyl auristatin or a functional analog thereof or a functional derivative thereof, and wherein the antibody-drug conjugate is administered at a dose ranging from about 1.5 mg/kg to about 2.1 mg/kg.
(canceled)
(canceled)
6-11. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
33-50. (canceled)
Dependencies are inferred from the claim text.